MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFRtherapeutics

---

AK S., TUNCA B., ERTAŞ H., UĞRAŞ N., ÖZTÜRK E., YILMAZLAR A. T., ...More

TAT 2018 – Targeted Anticancer Therapies, 5 - 07 March 2018, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Bursa Uludag University Affiliated: Yes